PERSPECTIVE THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
PERSPECTIVE THERAPEUTICS, INC. (CATX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 4.11 million shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-03-16
- PERSPECTIVE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-12-31 was 7.84M shares.
- PERSPECTIVE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-09-30 was 725.00K shares, a 82.88% decline year-over-year.
- PERSPECTIVE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-06-30 was 10.30M shares, a 4926.83% increase year-over-year.
- PERSPECTIVE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2023-03-31 was 2.80M shares.
- PERSPECTIVE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 4.11M shares, a 37.30% increase from fiscal 2024.
- PERSPECTIVE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 2.99M shares, a 86.18% decline from fiscal 2023.
- PERSPECTIVE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 21.67M shares.
- PERSPECTIVE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 3.27M shares, a 717.28% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 0 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | 4.11M shares 10-K · filed 2026-03-16 | ||||
| 2024-12-31 | 2.99M shares 10-K/A · filed 2025-03-28 | ||||
| 2023-12-31 | 7.84M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | 8.56M shares derived: sum of 2 quarters · filed 2024-03-28 | 18.87M shares derived: sum of 3 quarters · filed 2024-03-28 | 21.67M shares 10-K · filed 2024-03-28 | |
| 2023-09-30 | 725.00K shares 10-Q · filed 2023-11-14 | 11.03M shares derived: sum of 2 quarters · filed 2023-11-14 | 13.83M shares 10-Q · filed 2023-11-14 | 13.83M shares derived: sum of 4 quarters · filed 2024-03-28 | |
| 2023-06-30 | 10.30M shares 10-Q · filed 2023-08-11 | 13.11M shares 10-Q · filed 2023-08-11 | 13.11M shares derived: sum of 3 quarters · filed 2024-03-28 | 17.34M shares derived: sum of 4 quarters · filed 2024-03-28 | |
| 2023-03-31 | 2.80M shares 10-Q · filed 2023-05-15 | 2.80M shares derived: sum of 2 quarters · filed 2024-03-28 | 7.04M shares derived: sum of 3 quarters · filed 2024-03-28 | 7.24M shares derived: sum of 4 quarters · filed 2024-03-28 | |
| 2022-12-31 | 0.00 shares derived: 10-K 6 month − 10-Q 3 month · filed 2024-03-28 | 4.24M shares 10-K · filed 2024-03-28 | 4.44M shares derived: sum of 3 quarters · filed 2024-03-28 | 4.44M shares derived: sum of 4 quarters · filed 2024-03-28 | |
| 2022-09-30 | 4.24M shares 10-Q · filed 2023-11-14 | 4.44M shares derived: sum of 2 quarters · filed 2023-11-14 | 4.44M shares 10-Q · filed 2023-11-14 | 4.55M shares derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | 205.00K shares 10-Q · filed 2023-08-11 | 205.00K shares 10-Q · filed 2023-08-11 | 317.50K shares derived: sum of 3 quarters · filed 2023-08-11 | 3.27M shares 10-K · filed 2024-03-28 | |
| 2022-03-31 | 0.00 shares 10-Q · filed 2023-05-15 | 112.50K shares derived: sum of 2 quarters · filed 2023-05-15 | 3.06M shares 10-Q · filed 2022-05-13 | 3.30M shares derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | 112.50K shares 10-Q · filed 2022-02-09 | 3.06M shares 10-Q · filed 2022-02-09 | 3.30M shares derived: sum of 3 quarters · filed 2023-05-01 | 3.42M shares derived: sum of 4 quarters · filed 2023-05-01 | |
| 2021-09-30 | 2.95M shares 10-Q · filed 2022-11-14 | 3.19M shares derived: sum of 2 quarters · filed 2023-05-01 | 3.31M shares derived: sum of 3 quarters · filed 2023-05-01 | 3.31M shares derived: sum of 4 quarters · filed 2023-05-01 | |
| 2021-06-30 | 235.00K shares derived: 10-KT 12 month − 10-Q 9 month · filed 2023-05-01 | 360.00K shares derived: sum of 2 quarters · filed 2023-05-01 | 360.00K shares derived: sum of 3 quarters · filed 2023-05-01 | 400.00K shares 10-KT · filed 2023-05-01 | |
| 2021-03-31 | 125.00K shares 10-Q · filed 2022-05-13 | 125.00K shares derived: sum of 2 quarters · filed 2022-05-13 | 165.00K shares 10-Q · filed 2022-05-13 | 1.46M shares derived: sum of 4 quarters · filed 2023-05-01 | |
| 2020-12-31 | 0.00 shares 10-Q · filed 2022-02-09 | 40.00K shares 10-Q · filed 2022-02-09 | 1.33M shares derived: sum of 3 quarters · filed 2023-05-01 | 1.33M shares derived: sum of 4 quarters · filed 2023-05-01 | |
| 2020-09-30 | 40.00K shares 10-Q · filed 2021-11-10 | 1.33M shares derived: sum of 2 quarters · filed 2023-05-01 | 1.33M shares derived: sum of 3 quarters · filed 2023-05-01 | 1.36M shares derived: sum of 4 quarters · filed 2023-05-01 | |
| 2020-06-30 | 1.29M shares derived: 10-KT 12 month − 10-Q 9 month · filed 2023-05-01 | 1.29M shares derived: sum of 2 quarters · filed 2023-05-01 | 1.32M shares derived: sum of 3 quarters · filed 2023-05-01 | 1.33M shares 10-KT · filed 2023-05-01 | |
| 2020-03-31 | 0.00 shares 10-Q · filed 2021-05-14 | 30.00K shares derived: sum of 2 quarters · filed 2021-05-14 | 40.00K shares 10-Q · filed 2021-05-14 | 1.03M shares derived: sum of 4 quarters · filed 2021-09-27 | |
| 2019-12-31 | 30.00K shares 10-Q · filed 2021-02-09 | 40.00K shares 10-Q · filed 2021-02-09 | 1.03M shares derived: sum of 3 quarters · filed 2021-09-27 | 1.05M shares derived: sum of 4 quarters · filed 2021-09-27 | |
| 2019-09-30 | 10.00K shares 10-Q · filed 2020-11-13 | 1.00M shares derived: sum of 2 quarters · filed 2021-09-27 | 1.02M shares derived: sum of 3 quarters · filed 2021-09-27 | 1.18M shares derived: sum of 4 quarters · filed 2021-09-27 | |
| 2019-06-30 | 990.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-27 | 1.01M shares derived: sum of 2 quarters · filed 2021-09-27 | 1.17M shares derived: sum of 3 quarters · filed 2021-09-27 | 1.25M shares 10-K · filed 2021-09-27 | |
| 2019-03-31 | 25.00K shares 10-Q · filed 2020-05-13 | 180.00K shares derived: sum of 2 quarters · filed 2020-05-13 | 262.50K shares 10-Q · filed 2020-05-13 | 1.30M shares derived: sum of 4 quarters · filed 2020-09-25 | |
| 2018-12-31 | 155.00K shares 10-Q · filed 2020-02-12 | 237.50K shares 10-Q · filed 2020-02-12 | 1.27M shares derived: sum of 3 quarters · filed 2020-09-25 | 1.29M shares derived: sum of 4 quarters · filed 2020-09-25 | |
| 2018-09-30 | 82.50K shares 10-Q · filed 2019-11-13 | 1.12M shares derived: sum of 2 quarters · filed 2020-09-25 | 1.13M shares derived: sum of 3 quarters · filed 2020-09-25 | 1.13M shares derived: sum of 4 quarters · filed 2020-09-25 | |
| 2018-06-30 | 1.03M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-25 | 1.05M shares derived: sum of 2 quarters · filed 2020-09-25 | 1.05M shares derived: sum of 3 quarters · filed 2020-09-25 | 1.13M shares 10-K · filed 2020-09-25 | |
| 2018-03-31 | 15.00K shares 10-Q · filed 2019-05-10 | 15.00K shares derived: sum of 2 quarters · filed 2019-05-10 | 90.00K shares 10-Q · filed 2019-05-10 | 2.22M shares derived: sum of 4 quarters · filed 2019-09-27 | |
| 2017-12-31 | 0.00 shares 10-Q · filed 2019-02-13 | 75.00K shares 10-Q · filed 2019-02-13 | 2.21M shares derived: sum of 3 quarters · filed 2019-09-27 | 2.21M shares derived: sum of 4 quarters · filed 2019-09-27 | |
| 2017-09-30 | 75.00K shares 10-Q · filed 2018-11-09 | 2.21M shares derived: sum of 2 quarters · filed 2019-09-27 | 2.21M shares derived: sum of 3 quarters · filed 2019-09-27 | 2.23M shares derived: sum of 4 quarters · filed 2019-09-27 | |
| 2017-06-30 | 2.13M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-27 | 2.14M shares derived: sum of 2 quarters · filed 2019-09-27 | 2.15M shares derived: sum of 3 quarters · filed 2019-09-27 | 2.15M shares 10-K · filed 2019-09-27 | |
| 2017-03-31 | 10.00K shares 10-Q · filed 2018-05-04 | 20.00K shares derived: sum of 2 quarters · filed 2018-05-04 | 20.00K shares 10-Q · filed 2018-05-04 | 723.00K shares derived: sum of 4 quarters · filed 2018-09-26 | |
| 2016-12-31 | 10.00K shares 10-Q · filed 2018-02-09 | 10.00K shares 10-Q · filed 2018-02-09 | 713.00K shares derived: sum of 3 quarters · filed 2018-09-26 | 1.18M shares derived: sum of 4 quarters · filed 2018-09-26 | |
| 2016-09-30 | 0.00 shares 10-Q · filed 2017-11-14 | 703.00K shares derived: sum of 2 quarters · filed 2018-09-26 | 1.17M shares derived: sum of 3 quarters · filed 2018-09-26 | 1.19M shares derived: sum of 4 quarters · filed 2018-09-26 | |
| 2016-06-30 | 703.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-09-26 | 1.17M shares derived: sum of 2 quarters · filed 2018-09-26 | 1.19M shares derived: sum of 3 quarters · filed 2018-09-26 | 1.19M shares 10-K · filed 2018-09-26 | |
| 2016-03-31 | 462.50K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-10 | 482.50K shares derived: sum of 2 quarters · filed 2017-05-10 | 482.50K shares 10-Q · filed 2017-05-10 | 877.50K shares derived: sum of 4 quarters · filed 2017-09-28 | |
| 2015-12-31 | 20.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-09 | 20.00K shares 10-Q · filed 2017-02-09 | 415.00K shares derived: sum of 3 quarters · filed 2017-09-28 | ||
| 2015-09-30 | 0.00 shares 10-Q · filed 2016-11-09 | 395.00K shares derived: sum of 2 quarters · filed 2017-09-28 | |||
| 2015-06-30 | 395.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-28 | 395.00K shares 10-K · filed 2017-09-28 | |||
| 2015-03-31 | 0.00 shares 10-Q · filed 2016-05-10 | ||||
| 2014-06-30 | 315.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-09 | 315.00K shares derived: sum of 2 quarters · filed 2016-09-09 | 315.00K shares derived: sum of 3 quarters · filed 2016-09-09 | 380.00K shares 10-K · filed 2016-09-09 | |
| 2014-03-31 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-05-15 | 0.00 shares derived: sum of 2 quarters · filed 2015-05-15 | 65.00K shares 10-Q · filed 2015-05-15 | ||
| 2013-12-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-02-17 | 65.00K shares 10-Q · filed 2015-02-17 | |||
| 2013-09-30 | 65.00K shares 10-Q · filed 2014-11-14 | ||||
| 2013-09-06 | 15.00K shares 10-Q · filed 2015-05-15 | ||||
| 2013-09-05 | 50.00K shares 10-Q · filed 2015-05-15 | ||||
| 2012-06-30 | 110.00K shares 10-K · filed 2013-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |